Bruker Corporation

NASDAQ:BRKR

Medical - Devices

Healthcare
$63.26 -1.92%

-$1.07 today

Market cap
$9.66B
Beta
1.30
P/E (TTM)
-718.1
EPS (TTM)
-$0.08
Dividend yield
0.37%
52W Low $28.53High $64.54

Volume 1.73M

Average 2.41M

BRKR Total Debt

Short-term and long-term borrowings combined.

Bruker CorporationNASDAQ: BRKR

Total Debt · Q2 FY2026 · quarter ended Jun 2026

Total debt falls 21.3% from a year ago

Total debt stood at $1.92B at the end of Q2 FY2026, down 21.3% from a year earlier and up 14.6% from the prior quarter. Over 3 fiscal years it compounded at +17.2% a year.

Context

  • Total debt amounted to 31.6% of total assets at the end of Q2 FY2026, down 6.8 pp from a year earlier.
  • Total debt increased in 2 of the last 3 fiscal years.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -21.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.92B+14.6% QoQ
Last fiscal yearDec 2025
$2.04B-9.0% YoY
Year agoJun 2025
$2.44B-21.3% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-21.3%——
1 year-9.0%——
3-year CAGR+17.2%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
2.04B USD
Year-over-year change
-9.0%
4-year CAGR
+10.0%

Total Debt vs competitors

How BRKR compares with its peers on the latest reported figures

  • BRKR's Jun 2026 total debt of $1.92B is the 7th highest of the 11 companies compared; the peer median is $2.73B.
  • Its year-over-year change of -21.3% is the 10th highest of 11, against a peer median of +7.2%.
  • Total debt amounts to 31.6% of total assets for BRKR, versus a peer median of 28.1%.
BRKR Competitors Peer median
Total Debt for BRKR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$41.37B +15.9%+3.0%36.2%
DHRDanaher CorporationSep 2026$26.48B +57.1%-3.7%28.4%
WATWaters CorporationJul 2026$5.25B +241.5%-3.6%21.2%
AAgilent Technologies, Inc.Jul 2026$3.95B +15.8%+6.6%28.3%
RVTYRevvity, Inc.Jul 2026$3.34B -1.0%-8.5%27.7%
MTDMettler-Toledo International Inc.Jun 2026$2.11B -3.3%+3.2%57.5%
BRKRBruker CorporationJun 2026$1.92B -21.3%+17.2%31.6%
QGENQiagen N.V.Jun 2026$1.64B +13.8%-6.5%27.9%
BIOBio-Rad Laboratories, Inc.Jun 2026$1.2B -14.4%+3.3%11.7%
PACBPacific Biosciences of California, Inc.Mar 2026$703.39M +0.6%-7.1%89.9%
TECHBio-Techne CorporationSep 2026$285.56M -27.6%-14.0%10.8%
Peer median (excluding BRKR) $2.73B+7.2%-3.6%28.1%

Competitors are the stored peer set for BRKR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.07B645.5M488.3M183.4M298.8M
Short-term Investments100M0000
Net Receivables416.9M595.3M621.8M701.2M736M
Inventory710.1M800.1M968.3M1.07B1.09B
Other Current Assets176.6M29M30.3M39.6M47.9M
Total Current Assets2.47B2.11B2.16B2.05B2.21B
Property, Plant & Equipment (Net)466M538.2M691.4M814.8M910.6M
Goodwill339.5M457.6M582.6M1.51B1.55B
Intangible Assets211.8M270.9M330.5M912.5M899.6M
Long-term Investments00008.2M
Tax Assets90.1M76.8M297.2M286.2M421.7M
Other Non-current Assets70.8M155.1M184M232.7M241.1M
Total Non-current Assets1.18B1.5B2.09B3.75B4.03B
Total Assets3.65B3.61B4.25B5.81B6.24B
Account Payables147.4M178.4M202.7M234.1M215.9M
Short-term Debt112.4M18.7M121.2M32.5M51.8M
Tax Payables90.5M104M157.4M142.5M0
Deferred Revenue335.9M370.2M400M438.2M441.3M
Other Current Liabilities156.4M159.9M218.3M300.3M302.8M
Total Current Liabilities938.5M914.3M1.2B1.28B1.28B
Long-term Debt1.22B1.2B1.16B2.06B1.69B
Deferred Tax Liabilities46M62.3M67.7M118.5M112.5M
Deferred Revenue (Non-current)50.2M101.6M91.5M100M109.1M
Other Non-current Liabilities266.9M166.5M240.2M311M239.2M
Total Non-current Liabilities1.63B1.57B1.63B2.71B2.45B
Total Liabilities2.57B2.48B2.84B3.99B3.73B
Common Stock1.7M1.7M1.7M1.8M1.8M
Retained Earnings1.66B1.93B2.32B2.41B2.36B
Accumulated OCI(8.2M)14.8M6M(103.5M)(79.5M)
Other Stockholders Equity00000
Minority Interest14.3M18M36.1M34M53.8M
Total Equity1.08B1.13B1.41B1.82B2.51B
Total Debt1.39B1.27B1.38B2.25B2.04B
Net Debt325.7M624.9M891.3M2.06B1.74B

Bruker Corporation

NASDAQ:BRKR

Intrinsic Alpha fair value

Locked

Current Price

$63.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.